BNIP3 and DAPK1 methylation in peripheral blood leucocytes are noninvasive biomarkers for gastric cancer
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Gene methylation in gastric cancerClinica Chimica Acta, 2013
- DNA Methylation and Apoptosis Resistance in Cancer CellsCells, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- DNA Methylation in Peripheral Blood: A Potential Biomarker for Cancer Molecular EpidemiologyJournal of Epidemiology, 2012
- Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancerOncology Reports, 2011
- Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinomaClinica Chimica Acta, 2009
- BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functionsOncogene, 2008
- DAPK promotor methylation is an early event in colorectal carcinogenesisCancer Letters, 2006
- The Role of DNA Methylation in Mammalian EpigeneticsScience, 2001